Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy

[1] Xu L(2018)The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology J Hematol Oncol 11 33-56

[2] Chen H(2019)Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation Front Med 13 45-284

[3] Chen J(2018)Update on current research into haploidentical hematopoietic stem cell transplantation Expert Rev Hematol 11 273-1758

[4] Han M(2017)Quality of life after allogeneic hematopoietic cell transplantation according to affected organ and severity of chronic graft-versus-host disease Biol Blood Marrow Transplant 23 1749-177

[5] Huang H(2005)Prophylaxis and treatment of chronic graft versus host disease Zhonghua Er Ke Za Zhi 43 174-235

[6] Lai Y(2018)Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation Hematol Am Soc Hematol Educ Program 2018 228-954

[7] Lv M(2018)Neurological complications of hematopoietic cell transplantation in children and adults Neural Regen Res 13 945-159

[8] Chang Y(2019)Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation Acta Pharmacol Sin 40 151-1098

[9] Huang X(1997)Toxicities of tacrolimus and cyclosporin a after allogeneic blood stem cell transplantation Bone Marrow Transplant 20 1095-170

[10] Sun YQ(2010)Early central nervous system complications after allogeneic hematopoietic stem cell transplantation in children Kor J Hematol 45 164-1904

[1] Xu L(2018)The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology J Hematol Oncol 11 33-56

[2] Chen H(2019)Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation Front Med 13 45-284

[3] Chen J(2018)Update on current research into haploidentical hematopoietic stem cell transplantation Expert Rev Hematol 11 273-1758

[4] Han M(2017)Quality of life after allogeneic hematopoietic cell transplantation according to affected organ and severity of chronic graft-versus-host disease Biol Blood Marrow Transplant 23 1749-177

[5] Huang H(2005)Prophylaxis and treatment of chronic graft versus host disease Zhonghua Er Ke Za Zhi 43 174-235

[6] Lai Y(2018)Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation Hematol Am Soc Hematol Educ Program 2018 228-954

[7] Lv M(2018)Neurological complications of hematopoietic cell transplantation in children and adults Neural Regen Res 13 945-159

[8] Chang Y(2019)Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation Acta Pharmacol Sin 40 151-1098

[9] Huang X(1997)Toxicities of tacrolimus and cyclosporin a after allogeneic blood stem cell transplantation Bone Marrow Transplant 20 1095-170

[10] Sun YQ(2010)Early central nervous system complications after allogeneic hematopoietic stem cell transplantation in children Kor J Hematol 45 164-1904